DD202-114 is a potent and selective GLP1R agonist. DD202-114 inhibits hERG with an IC50 of 15.9 µM. DD202-114 exhibits strong CYP2C8 inhibition with an IC50 of 0.22 µM. DD202-114 promotes cAMP accumulation. DD202-114 reduces blood glucose levels and food intake. DD202-114 has the potential to be used in the study of type 2 diabetes mellitus (T2DM) and obesity[1][2].
Molecular Weight:
586.65
Purity:
98.47
CAS Number:
[2886728-09-0]
Formula:
C33H35FN4O5
Target:
Cytochrome P450,GLP Receptor,Potassium Channel
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted